HealthQuill
Teenage is the time of celebrity worship syndrome, fandom and social media influence. This age group is highly susceptible to media influence due to preoccupation with identity, making them identify with and model what they view. 
Drugs Health Opinion Pharma

Opinion: Time for young celebrity idolators to turn reels into reality

By Aparna S March 19, 2024: Substance use disorder is a major public health problem across the globe, and India is no exception..

Read More
Neurological conditions affect 3.4 billion people or 43% globally, making them the top contributor to the global disease burden ahead of cardiovascular diseases, according to an analysis.
Drugs Health Pharma

Neurological conditions top global cause of disease burden

HQ Team March 18, 2023: Neurological conditions affect 3.4 billion people or 43% globally, making them the top contributor to the global disease.

Read More
At least 57 women and girls in Sudan were at the receiving end of sexually-related violence since a conflict between warring factions of the military government in the country began in April, the UN stated.
Drugs Health Medical

Female genital mutilation sees a 15% increase worldwide; UNICEF

HQ Team March 18, 2024: There are over 230 million victims of female genital mutilation worldwide, according to the UNICEF. This is an.

Read More
Gene editing technology called CRISPR can help diagnose nontuberculous mycobacteria infections in less than two hours from six months, researchers found.
Drugs Health Pharma

Gene-editing cuts diagnosis time for mycobacteria infection

HQ Team March 18, 2024: A gene editing technology called CRISPR can help diagnose nontuberculous mycobacteria infections in less than two hours from.

Read More
The exact aetiology of the disease is still unknown. A combination of genetics and environmental factors appears to be responsible. Its onset usually occurs around 20-40 years of age and women are 2-3 times more likely to develop MS.
Drugs Health Opinion Pharma

Opinion: Ocrevus takes a step forward in treating multiple sclerosis

By K. Leelamoni March 18, 2024: Akhila came up with a surprise statement while I was talking to her. “Mam’ I have multiple.

Read More
Lysolipid, a byproduct of the human immune response to viruses and bacteria, may be behind lung instability caused due a life-threatening illness— acute respiratory distress syndrome, researchers said.
Drugs Health Pharma

Excess lysolipids may be main reason for acute respiratory distress syndrome

HQ Team March 13, 2024: Lysolipid, a byproduct of the human immune response to viruses and bacteria, may be behind lung instability caused.

Read More
Cognitive behaviour therapy could be an effective way to reduce the risks of developing postpartum mental health conditions, according to a study.
Drugs Health Pharma

Cognitive therapy may cut risk of postpartum depression

HQ Team March 13, 2024: Cognitive behavioural therapy could be an effective way to reduce the risks of developing postpartum mental health conditions,.

Read More
Women perform an estimated 76% of all unpaid healthcare activities and work that is done primarily by women tends to be paid less and have poor working conditions, according to a WHO report.
Drugs Health Pharma

Women do 76% of all unpaid healthcare work, says WHO report

HQ Team March 13, 2024: Women perform an estimated 76% of all unpaid healthcare activities and work that is done primarily by women.

Read More
The global mortality rate in children aged under five years has declined by 51% since 2000 and reached a historic low of 4.9 million in 2022, according to a WHO body.
Drugs Health Pharma

Global mortality rate in children under five years falls to historic low

HQ Team March 13, 2024: The global mortality rate in children aged under five years has declined by 51% since 2000 and reached.

Read More
Pfizer Inc., announced that a late-stage study on its Adcetris drug, for treating the most common lymphoma, yielded positive results and improved overall survival rates.
Drugs Health Pharma

Pfizer says trials on lymphoma drug ‘positive,’ extends life of patients 

HQ Team March 12, 2024: Pfizer Inc., announced that a late-stage study on its Adcetris drug, for treating the most common lymphoma, yielded.

Read More